Sinew Pharma Inc. (TPEX: 6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
50.10
+0.10 (0.20%)
Nov 20, 2024, 2:59 PM CST
-28.43%
Market Cap 3.57B
Revenue (ttm) n/a
Net Income (ttm) -178.48M
Shares Out 71.33M
EPS (ttm) -2.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 153,680
Open 49.70
Previous Close 50.00
Day's Range 49.50 - 52.60
52-Week Range 49.05 - 80.90
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 12, 2024

About Sinew Pharma

Sinew Pharma Inc., a biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan; and SNP-630, a pre-clinical drug for treating patients with non-alcoholic steatohepatitis. It is also developing SNP-810 for use in analgesic and antipyretic indications; and SNP-830 and SNP-840, which are used as hepatotoxicit... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 52
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.